CROSS COUNTRY HEALTHCARE INC Earnings Per Share Disclosure
| Year Ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| (amounts in thousands, except per share data) | |||||||||||||||||
| Numerator: | |||||||||||||||||
| Net (loss) income attributable to common stockholders - Basic and Diluted | $ | (94,852) | $ | (14,556) | $ | 72,631 | |||||||||||
| Denominator: | |||||||||||||||||
| Weighted average common shares - Basic | 32,409 | 33,379 | 35,158 | ||||||||||||||
| Effective of diluted shares: | |||||||||||||||||
| Share-based awards | — | — | 318 | ||||||||||||||
Weighted average common shares - Diluteda | 32,409 | 33,379 | 35,476 | ||||||||||||||
| Net (loss) income per share attributable to common stockholders - Basic | $ | (2.93) | $ | (0.44) | $ | 2.07 | |||||||||||
| Net (loss) income per share attributable to common stockholders - Diluted | $ | (2.93) | $ | (0.44) | $ | 2.05 | |||||||||||
| Year Ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| (amounts in thousands) | |||||||||||||||||
| Share-based awards | 163 | 339 | 2 | ||||||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 9, 2026 | Showing above |
| 2024 | Mar 5, 2025 | |
| 2023 | Feb 23, 2024 | |
| 2022 | Feb 23, 2023 | |
| 2020 | Feb 25, 2021 | |
| 2019 | Mar 5, 2020 | |
| 2018 | Mar 1, 2019 | |
| 2016 | Mar 3, 2017 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.